Mask, pills, stack of cash Among the 10 largest pharmaceutical companies by revenue, seven spent more on marketing expenses in 2020 than research and development.

What's to blame for the high costs of our health care system? It depends on who you ask. Drug manufacturers will point to the high cost of health insurance, and health insurers will point to the high cost of drugs.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Emily Payne

Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.

Core and Group Health
Health Care Reform
Cost-Containment